Workplace drug testing in Switzerland

TL;DR

• No blanket right to test – proportionality is required (Art. 328 CO, Art. 26 OLT 3).
• Permitted for safety-critical roles (drivers, machine ops, work at heights, medical staff).
• Always needed: employee consent or a clear contractual basis.
• SUVA and Addiction Switzerland recommend testing only as the last step of a prevention concept.

Legal framework

The employer owes a duty of care (Art. 328 CO) but must respect personality rights. Drug testing is highly intrusive and only allowed if it is suitable, necessary and proportionate.

Key rules: Art. 26 OLT 3 (control systems) and collective agreements (CBA, internal directives). Testing “just because” is not defensible – not even with a contract clause.

Safety-critical roles

• Professional drivers, train/plane crew, crane operators, construction workers.
• Medical staff (anaesthesia, ER, operating theatre).
• Security/police services, weapons handling.
• High-risk chemical/pharma production.

Swiss employment law: when a test is lawful and what you may refuse

A Swiss employer cannot simply test at will. The framework is Art. 328 and 328b CO (personality protection, data processing only where necessary), Art. 26 ArGV 3 (no behavioural surveillance without objective cause) and the revised Data Protection Act. Testing is generally lawful in safety-critical roles – train drivers, crane operators, pilots, professional drivers, machine work – or on concrete suspicion of impairment on duty. Suspicionless blanket testing in an office is almost never proportionate.

In practice you may refuse a test, but you carry the employment-law risk if the instruction is lawful and anchored in your contract or staff regulations. It is usually smarter to document the procedure in writing, insist on a confirmation analysis, and limit what reaches the employer to a "fit / unfit" statement issued by the company physician. The raw medical value does not belong in your personnel file.

Procedure in the event of reasonable suspicion and involvement of the trust physician

If a concrete suspicion of impairment due to substance use arises in the company, the employer may not take compulsory medical measures on their own authority. The procedure must be clearly regulated and safeguard the personal rights of the employee. First, the supervisor seeks a confidential discussion to directly address abnormalities such as a lack of concentration or motor disorders. If the suspicion is substantiated that there is an acute threat to occupational safety, temporary suspension or referral for a medical assessment can be ordered. A direct on-site drug test is impermissible without express, voluntary consent.

For the implementation and evaluation, involving a trusted medical officer or an occupational health service is highly recommended. The trusted medical officer is bound by medical confidentiality and may only inform the employer whether the person concerned is fit for work for the contractually agreed activity. Detailed laboratory values, the type of substances detected, or private consumption habits must not be shared with the HR department without an explicit waiver of confidentiality. This protects the employee's privacy and prevents unlawful data processing under the Data Protection Act.

• Documentation of concrete behavioral abnormalities instead of vague suspicions by superiors.
• Offering a clarifying one-on-one discussion before initiating formal steps.
• Involvement of an independent trusted medical officer to safeguard medical confidentiality.
• Limiting feedback to the company to the sole assessment of the current fitness for work.

Employment law consequences and the principle of proportionality

Refusing a legally ordered drug test can have tangible consequences for employees. If a corresponding clause for safety-sensitive activities is anchored in the employment contract, a collective employment agreement, or the company regulations, the duty to cooperate applies. If an employee in such a position refuses the test despite reasonable suspicion, this can be deemed a breach of the contractual duty of loyalty. In this case, the employer is entitled to take ordinary employment law measures, such as issuing a written warning, or to initiate ordinary termination in the event of repeated refusal.

Dismissal with immediate effect, on the other hand, is subject to extremely high hurdles and is only permissible in exceptional cases under Swiss employment law. It requires that continuing the employment relationship is absolutely unreasonable for the employer in good faith. This may be the case if the refusal of the test, combined with the simultaneous presence of severe symptoms of impairment, creates an acute, significant danger to the life and limb of colleagues or third parties. For office employees without a safety risk, termination with immediate effect due to a refusal to test is generally abusive and legally untenable.

• Written warning as a milder measure prior to any potential termination of the employment relationship.
• Possibility of ordinary termination in the event of a persistent breach of contractual duties to cooperate.
• Dismissal with immediate effect only applicable in the event of an acute, serious threat to operational safety.
• Right to challenge an abusive termination in the case of disproportionate testing demands in the office.

Swiss Practice: Recreational Use, Pilot Trials and Inability to Drive

In Switzerland, the distinction between legal recreational behavior and work performance is a central point of contention. Since August 2022, medical cannabis can be prescribed by a doctor without an FOPH exceptional licence, which further refines the legal assessment in the workplace. In addition, scientific pilot trials under the Narcotics Act are underway in various cities, enabling the legal purchase of cannabis containing THC. However, participation in such projects or the private consumption of legal CBD cannabis with a total THC content of less than one percent does not exempt employees from the obligation to appear at work sober and fully fit for work.

Particular caution is advised for employees who are required to drive a company vehicle as part of their professional activities. In Swiss road traffic, a strict zero-tolerance practice applies, with a statutory THC detection limit of 1.5 micrograms per litre of blood. Since THC is broken down slowly by the body, private consumption at the weekend can still lead to a proven inability to drive days later. If an employee loses their driving licence due to a positive test result in road traffic, this can constitute a legitimate ground for ordinary termination in the case of drivers or field staff, as the contractually owed work performance can no longer be delivered.

• Strict separation of legal recreational consumption and unrestricted fitness for work during working hours.
• Consideration of medically prescribed medical cannabis within the scope of an individual risk assessment.
• Compliance with the strict limit of 1.5 micrograms of THC per litre of blood when using company vehicles.
• Potential loss of employment in the event of a driving ban for employees who are strictly dependent on their driving licence.

Sources of Error in Rapid Tests and the Right to a Confirmatory Analysis

The rapid urine or saliva tests frequently used in daily business operations are designed purely as screening procedures and have a relevant error rate. These tests only react to the presence of metabolites and cannot provide any information about acute impairment or the exact time of consumption. Furthermore, there is a risk of cross-reactions, where harmless medications, dietary supplements, or the consumption of legal CBD cannabis lead to a false-positive test result. A positive rapid test must therefore never be used as the sole basis for severe employment law sanctions.

Affected employees have the right in any case to challenge the result of a rapid test and demand a precise confirmatory analysis. This is carried out by an accredited laboratory using gas or liquid chromatography methods in blood or urine. Only these scientifically sound procedures can differentiate between inactive metabolites and acutely active THC. The costs of such a confirmatory analysis must generally be borne by the employer if the initial suspicion proves to be unfounded. Until the final laboratory report is available, the presumption of innocence applies in the interest of protecting personal rights.

• Limited conclusiveness of rapid tests regarding the actual time of consumption.
• Risk of false-positive results due to cross-reactions with over-the-counter medications.
• Legal entitlement to a precise laboratory analysis to verify unclear rapid test results.
• Assumption of laboratory costs by the company in the event of a negative confirmatory result.

FAQ